About
Technology
Issues
FAQ
Links
Official Page
Pharmacokinetic bioequivalence, safety, and immunogenicity of GB222, a bevacizumab biosimilar candidate, and bevacizumab in Chinese healthy males: a randomized clinical trial
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.